Zulaika, Garazi
Otieno, Fredrick O.
Mason, Linda
van Eijk, Anna Maria
Bhaumik, Runa
Green, Stefan J.
Phillips-Howard, Penelope A.
Mehta, Supriya D.
Funding for this research was provided by:
National Institutes of Health and National Institute of Allergy and Infectious Diseases (R01AI170564)
Article History
Received: 9 May 2024
Accepted: 23 October 2024
First Online: 8 November 2024
Declarations
:
: This study and associated informed consent forms were approved by the institutional review boards (IRBs) of Jaramogi Oginga Odinga Teaching and Referral Hospital (ISERC/JOOTRH/657/22), Rush University Medical Center (RUMC, 22040505), and Liverpool School of Tropical Medicine (LSTM, 22–076). Research permission was granted by the Kenya National Commission for Science, Technology, and Innovation (NACOSTI/P/24/33000), and the Kenya Poisons and Pharmacy Board provided approval for trialling menstrual cups in Kenya (PPB/ECCT/23/07/01/2023(443). Any necessary protocol amendments must be approved by these IRBs and communicated to the sponsor.
: Not applicable.
: The authors declare no competing interests.